Advertisement vbandhakavi, Author at Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

All articles by vbandhakavi 

Imara closes $63m Series B cross-over financing

The fundraise was co-led by new investors OrbiMed Advisors and Arix Bioscience plc and included investment from RA Capital and Rock Springs Capital. Existing investors New Enterprise Associates,